HealthQuest Capital and Samsara BioCapital led a $52m Series B round in Alpheus Medical.

Venture capital firms HealthQuest Capital and Samsara BioCapital led a $52m Series B round in Alpheus Medical, a private, clinical-stage oncology company pioneering sonodynamic therapy, with participation from OrbiMed, Action Potential Venture Capital, BrightEdge, American Cancer Society, the Brain Tumor Investment Fund and Sontag Innovation Fund. "This investment is a key inflection point for Alpheus and the glioblastoma community – advancing sonodynamic therapy from promise to clinical validation.With this support, we are poised to generate pivotal evidence that could help establish a new standard of care for newly diagnosed brain tumors," Vijay Agarwal, Alpheus Medical President and CEO.